1. Home
  2. FVRR vs XFOR Comparison

FVRR vs XFOR Comparison

Compare FVRR & XFOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fiverr International Ltd. no par value

FVRR

Fiverr International Ltd. no par value

HOLD

Current Price

$10.85

Market Cap

372.4M

ML Signal

HOLD

Logo X4 Pharmaceuticals Inc.

XFOR

X4 Pharmaceuticals Inc.

HOLD

Current Price

$4.03

Market Cap

407.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FVRR
XFOR
Founded
2010
2014
Country
Israel
United States
Employees
N/A
143
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
372.4M
407.5M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
FVRR
XFOR
Price
$10.85
$4.03
Analyst Decision
Buy
Strong Buy
Analyst Count
9
4
Target Price
$18.43
$9.00
AVG Volume (30 Days)
877.5K
362.3K
Earning Date
04-29-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.83
N/A
P/E Ratio
$22.05
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.67
$1.35
52 Week High
$34.13
$4.83

Technical Indicators

Market Signals
Indicator
FVRR
XFOR
Relative Strength Index (RSI) 49.49 48.34
Support Level $9.97 $3.97
Resistance Level $11.33 $4.09
Average True Range (ATR) 0.52 0.25
MACD -0.06 -0.06
Stochastic Oscillator 32.46 44.23

Price Performance

Historical Comparison
FVRR
XFOR

About FVRR Fiverr International Ltd. no par value

Fiverr International Ltd operates a online marketplace that enables sellers to offer digital services and buyers to purchase them The Company's platform features an extensive catalog of digital services that spans over hundreds of categories. Buyers can purchase digital services ranging from simple services such as logo design and blog post writing, to complex services such as video creation, website development and social media marketing. Also, the Company offers value-added services including subscription products, advertising solutions and financial tools designed to support marketplace users and enhance their business activities. The company generates maximum of its revenue from USA.

About XFOR X4 Pharmaceuticals Inc.

X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.

Share on Social Networks: